Tower Research Capital LLC (Trc) Senti Biosciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Senti Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,823 shares of SNTI stock, worth $8,372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,823
Previous 8,514
55.1%
Holding current value
$8,372
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SNTI
# of Institutions
18Shares Held
8.79MCall Options Held
0Put Options Held
0-
Nea Management Company, LLC Timonium, MD4.43MShares$9.69 Million0.12% of portfolio
-
8 Vc Gp I, LLC Austin, TX2.54MShares$5.56 Million8.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA707KShares$1.55 Million0.0% of portfolio
-
Intel Corp Santa Clara, CA596KShares$1.3 Million0.12% of portfolio
-
Geode Capital Management, LLC Boston, MA246KShares$537,8420.0% of portfolio
About Senti Biosciences, Inc.
- Ticker SNTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,757,100
- Market Cap $95.8M
- Description
- Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...